CEO Total Pay
$1.1M
FY2021 Summary Compensation, below median
The CEO earned $1.1M in FY2021 against median worker pay of $592,830 · Chemicals & Pharmaceuticals.
Data updated August 2026
Latest filing FY2021. This company's newest DEF 14A on file is for FY2021, not FY2025, so the figures on this page are from that earlier year and are not ranked against the FY2025 industry benchmark. Industry pages mark issuers like this one with a "Latest filing" label.
Answer first
Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.
Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.
A component-level pay breakdown is not reported in Aceragen, Inc.'s structured SEC pay-ratio disclosure. See our methodology →
Aceragen, Inc. stamps FLOOR · ELITE-MED at 2:1 against $592,830 median worker pay in FY2021. the CEO earned 2× the median employee ($592,830) in FY2021.
At $592,830 median worker pay, the FLOOR stamp is near pay-parity territory under LIGHT CEO total.
CEO Total Pay
$1.1M
FY2021 Summary Compensation, below median
Pay Ratio
2:1
Below typical
Aceragen, Inc. stamps FLOOR · ELITE-MED at 2:1 against $592,830 median worker pay in FY2021. The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Aceragen, Inc.'s $1.1M CEO total is at or below the $7.9M industry median CEO pay.
Aceragen, Inc. stamps FLOOR · LIGHT · ELITE-MED; grant-date fair value (not realized pay) is what the DEF 14A reports. Open Chemicals & Pharmaceuticals peers.
Read our methodology - how this data is sourced, computed, and verified. Aceragen, Inc. stamps FLOOR · ELITE-MED at 2:1 against $592,830 median worker pay in FY2021.
ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps FLOOR · LIGHT · ELITE-MED.
ABS(ceo_total_comp) peer at $1.1M (Δ $4K heavier vs Aceragen, Inc.); FLOOR · HIGH-MED vs this page's FLOOR · LIGHT · ELITE-MED.
ABS(ceo_total_comp) peer at $1.1M (Δ $10K lighter vs Aceragen, Inc.); FLOOR · HIGH-MED vs this page's FLOOR · LIGHT · ELITE-MED.
ABS(ceo_total_comp) peer at $1.1M (Δ $18K lighter vs Aceragen, Inc.); MODEST · LOW-MED vs this page's FLOOR · LIGHT · ELITE-MED.
ABS(ceo_total_comp) peer at $1.2M (Δ $25K heavier vs Aceragen, Inc.); FLOOR · PAR-MED vs this page's FLOOR · LIGHT · ELITE-MED.
Aceragen, Inc. stamps FLOOR · LIGHT · ELITE-MED inside SIC 28 - open the industry median board after the ABS peers.
See where FLOOR · LIGHT packages sit on the national leaderboard after reading Aceragen, Inc..
Aceragen, Inc.'s FLOOR stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.